Exhibition Preview | Nanodigmbio invites you to join us at Sapporo 2024 Annual Meeting of the Japan Society of Human Genetics (JSHG)
View: 757 / Time: 2024-09-30
01 Introduction to the Exhibition
The 69th Annual Meeting of the Japanese Society of Human Genetics (JSHG) will be held at the Grand Mercure Sapporo Odori Park in Sapporo, Japan from October 09 to 12, 2024. Since its founding in 1956, JSHG has been committed to advancing science through human genetics research, advancing the practice of clinical genetics, and applying disease and health research findings to health care and welfare systems, while disseminating genetics knowledge to society through education and public enlightenment.
JSHG 2023 was a great success, attracting a large number of international participants. This year's conference is also an excellent opportunity not only to share the latest scientific and technological achievements, but also to expand and strengthen international relations through scientific exchanges and personal interactions. The organizing committee of the Congress, made up of leading experts in the field of human genetics, is currently developing an attractive scientific programme of invited lectures, symposia, workshops and educational sessions.
02 Nanodigmbio TIME
【Exhibition Time】October 09 - 12, 2024
【Venue】Grand Mercure Sapporo Odori Park, Sapporo, Japan
【Nanodigmbio Booth】24 (3F)
03 Product Recommendation
μCaler Multi-scenario application solution
μCaler Hybrid System is a liquid phase hybridization capture system optimized for the targeted enrichment of small panels. μCaler NanoBlockers and μCaler Panel based on innovative scheme constitute a complete liquid phase hybridization capture system. Complete the entire process of capture library construction in a single day.
μCaler Panel is a commercialized or customized Panel based on the innovative design of Nanodigmbio's independent intellectual property rights, which can quickly find the binding position in the reaction system, and further stabilize after multiple probes are combined with the target area.
With this system, Nanodigmbio has launched μCaler DNA Full Screen System Comprehensive Solution and two sets of NGS-MRD solutions, namely: μCaler MRD Solution (Tumor-informed Assay) and μCaler AML MRD Comprehensive Solution (Tumor-uninformed Assay), It can also be applied to the detection of common cancer HotSpot mutation areas (μCaler HotSpot Panel), pathogen microbial detection, methylation detection (μCaler EMS Panel), etc.
One-Stop Service for Customized Probes
NAD Probe is a one-stop service created by Nanodigmbio, covering the entire process from probe design, probe production, quality inspection, optimization, and result delivery. Through strict quality control (QC) and optimized NGS QC services, we can provide our customers with high-quality customized hybridization capture solutions, covering the application types in addition to conventional mutation detection, which include methylation capture, RNA capture, and virus capture.